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EXPRESSION OF A DOMINANT NEGATIVE TYPE II TGf\} RECEPTOR IN TIlE 
EPIDERMIS OF TRANSGENIC MICE DOCUMENTS ITS ROLE IN MEDIATING GROwrn 
INHlBmON. X.-l. WanG. D.A. Greenhalgh.lA. Blckenbach. D.S. Bundman, R. Dcrynck' and 
~Departments of Cell Biology aDd Dermatology, Baylor College of Medicine, Houston, 
'IX and 'Department of GroWth and Development. University of Callfornla at San FranciscO, CA. 
TransfOrming growth faCtor Jl (TGf\}) ts a potent growth tnhlbltor of normal keraUnocytes. 
Homodlmers of type II TGFlI receptors and heicromerll of the type I and IT receptors arc believed 
to mediate TGf\} effects, however, It Is not clear whether the ScrfThr -kinase domo.ln of the type 
II receptor Is exclusively required to mediate the growth Inhlbltory effect of TGFJl In Iile 
epklermls. To test this, aDd to establish an In vivo model for studying Iile role of Iile TGf\} 
pathway In sldn carcinogenesiS, we have generated transgenic mice which overexpress a dominant 
negative type II TGf\} receptor (6/lRlI) In the epidermiS. The 6/lRII transgene was generated 
by deleting the ScrfThr -kinase domain of thc receptor, but retaining the ligand binding domo.ln 
and the transmembrane domain for dlmcrlzaUon. The truncated mouse lodcrln promoter (ML), 
which expresses transgenes In bolil basal and suprabasal layers of Iile epidermis, was utilized to 
lJIrget the 6/lRll to the epidermis (ML.6JlRlI). Newborn MLAIIRll mice exhibited a gross 
phenotype of a thickened and wrlnlded skin, and histologically the epidermis was markedly 
hyperplastic. The skin of thcse mice began to peel within three days, IndlcnUng progression 10 
a hyperkeratotic phenotype. In vivo labelUng wllil BrdU shoWed a 3-fold Increase In Iile mitotic 
rate OVer controls, with the labeled nucle! occurdng in both basal and suprabasal cells. These 
mice iuso exhibited aberrant expresSion of keratin 6 In Iile epidermis. These data document the 
role of the type II TGf\} receptor In medlnUng TGf\}-lnduced growth Inhlbltlon In the epidermis. 
TO daie, the ML.6jlRll mlcc arc viable and capable of producing p'0gcny with the nconalal 
phenotype. Since mutaUons genernUng dorninant negnUve forms of the type II TGf\} receptor 
have recently been detected In squamous. cell ClllClnomas, these transgenic mice should be useful 
In studylng loss of fwlcUonai type II TGFI! receptors at vadous stages of skin carcinogenesis. 
HB11 
IDENTIFICATION OF LABEL-RETAINING CELLS IN HUMAN SCALP EPIDERMIS 
AND HAIR FOLLICLE. Mclpo Christofidou-Solornidou* Motba Kalyanit Steven M 
Albelda* Gcorge COJsarelis+, DeplJi of 'Medicine and +Dermatology, University of 
Pcnnsylvania Medical Center, Pbiladelpbia, PA. 
The epidermis and hair folUcle are thought to contain s low-cycling stem cells that are 
responsible for repopulating tbese self-renewing tissues. 1110 transition of the hair follicle 
from telogen to anagen results in the formation of a new lower follicle that subscquenlly 
produces a new hair. In humans, the location of stem cells giving risc to Ihe regenerated 
hair follicle and hair is not clear. In mice, hair follicle si.e", cells bave bcen identified 
experimentally as label- retaining cells (LRC'S) in tht bl!lg! area of tbe hair follicle. The 
purpose of this study was to identify stem ceUs in humor. scalp by localizing LRC's in skin 
grafts transplanted onto severe combined immunodeficient (SCID) mice. Three weeks after 
grafting, BrdU was delivered continuously for 2 weeks using intraperitoneal mini pumps. 
During this lime many follicles were in trans ition from tclogen to anagcn. We reasoned that 
hair follicle stem cells would be labeled altbis point as they transiently proliferated to give 
rise to the new lower folUcle. After chasing for 4 monlbs, any rapidly proliferating cells 
would dilute their label and only slow-cycling (stem) cells should remain labeled. After Ihe 
chase period, no LRC's were found in the hair follicle bulb or lower ouler root shealh 
(ORS) below the insertion of the arector pili muscle. LRC's were only deteeled in the ORS 
near or above the inscnion site of the arector pili muscle. LRC's were also identified in the 
interfollicular epidermis within the rete ridges ,,,10 in tbe peri-infundibular "rca. These 
resulL< suggest that, similar to the mouse hair follicle, stem cells are locatcd in the bulge 
area of lhe human hair follicle, and not in the transient portion of the follicle. These resulls 
also suppon the concept that epidermal stem cells are located in rete ridges and in Iile peri-
infundibular region of interfollicular epidermis. 
HB12 
MOLECULAR BASIS OF VARIEGATE PORPHYRIA: FRAMESHIFT 
MUTATIONS IN THE PROTOPORPHYRINOGEN OXIDASE GENE. HaMut 
Lam, La~ssa Dr~an, Hui C . Tsou, Hans Merl<' Monica Peacocke, GOnter Goerzn-: 
Shlge ruassaK,aureen POh-htZ&alnCl(, Da Vid A. BICkers and An~ela M. Chns\iano . 
De pt. of DermatolOgy, columblamversllr" New York. NY ; 'Dep . of Dermalology. 
Unive rsity Hospital , Aachen, Germany; • Dept. 01 De rmatology, He inrich He ine 
University, DOsseldorf, Germany; 'The Rockefelie rUniversity Hospital. Ne w York, NY . 
The porrhYrlas are disorders which result from the inherited or acquired 
dysregulatlon 0 one of the eight enzymes in the heme biosynthetic palhway. 
Variegate porphyria (VP), is charactenzed by deficie ncies in protoporphyrinoge n 
oxidase (PPO) , and has recently been [jenelically linked (Z=6.62) to the PPO !lene on 
chromosome 1 q21. VP Is us ually Inhented as an a utos omal dominant trait With half-
normal levels of PPO, although rare recessive cases with <10% PPO activity have 
bee n reported. Cutaneous manifestations are present in affected individuals, and 
consist of blistering, fragilitY,scarring of sun-exposed skin and post-imllammatory 
hyperplgmentalion. Tne photosensitivity may exist alone or together with 
neurovisceral sy'mptoms which characterize the acute hepatic porphyrlas. We have 
ide ntilied two different frameshlft mutations In the PPO gene in two unrelated palients 
with VP. The lirst is an apparently de novo 2 bp insertion in exon 3, and the second is 
a 1 bp deletion In exon 10. 80th PPO mulations result in a frameshift and downstream 
premature lermlnationcodon, and bolh patients are heterozY\lOus lor these mutations. 
explalnlng why they have approximately 50% levels 01 reSidual PPO activity. The 
enzyme deficiencies elicited by these muta tions are likely to result from 
haplolnsufliclency due to nonsense-mediate d mRNA decay of the mulanl a lle le , and/or 
by 'dominant-negative interference 01 small amounts 01 mutant polypeptide wilh the 
wild-type . These two independe nt cases establish that premature termination codons 
in lhe PPO gene resull in dominantly Inhertted VP, and provide the basis for the design 
of enzyme replacement strategies for this disorder in the luture. 
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MUTATIONS IN THE PLECTIN GENE CAUSE EPIDERMOLYSIS 
BULLOSA WITH MUSCULAR DYSTROPHY. W.H. Irwin McLean Leena 
Pulkkinen Frances J.D. Smith Eii7.abelh L. Rugg R orcnel" Bullrich Robert E. 
Burgeson Satoshi Amano pavid L. Hudson. Katsushi Owari be John A. McGr .. th~ 
Robin A.J. Eady Irene M. Leigh E. Birgitte Lane Angela M. Chris tia no and Jount 
Uillo. Univ. of Dundee; CBRC Harvard Univ., BaSion, MA; Nagoya Univ.; S\. John' s 
Ins\. of Dermatology, London, U.K. ; Royal London Hospilal , and Jeffe rson Medical 
College, Philadelphia, PA. 
Plcctin. n high molecular weight cytomatri x protein. is an integra l part of 
hcm idesmosomcs. the basal cell-basement membrane allachmc nl complex, as well as a 
component of lhe sarcolemma in muscle. Epidermolysis bullosa (EB) is a heterogenous 
group of mcchano-bullous diseases, Hnd a specific variant (EB-MD) demo nstrates tissue 
separntion at the level of the hcmidesmosomes. and is associated with muscular dystrophy. 
Recently. we IU1VC shown neglltivc immunonuoresccncc sUli lling with a monoc l o ~al 
antibody HD-l, which recognizes a plectin epitopc, in the skin and muscle o f patients wl~h 
EB-MD. suggesting that plectin is the gene/protei n system for underlying muhllions III 
these patien ts. We havc cloned the human plectin eDNA and gene. which was mapped by 
F1SU to the most telomcric porti on of chromosome 8, corresponding to band 8q24. T he 
predicted protei n possesscs an actin bindi ng domai n at the N-!erminus , a cenlml r~d 
domain and n C-terminnl intermcdinte fil ament binding domain. Sequencing of plectlll 
eDNA. amplified from k.cratinocyte o r fibroblast mRNA by RT-peR rcvc.1lcd ho mozygous 
framcshift mutatio ns in two patienl". In o ne case, II homozygous 8 bp deleLion was noted 
while the second case WIIS homozygous for 118 bp insertion, both resulting in t runc~lti on o f 
the protein wiLhin the central rod domain. In both cases, the clinically una ffected 
cons~nguineous parents were heterozygous carriers of the same mutations . These results 
establish, for the fi rst time, the molecular basis o f EB-MD. nnd clcllrly dcmonstmtc the 
important slructuml role of plcetin in inlemlediate filamcnt -hcmidcsmosomc adherence. 
The role of plcctin in a s imihlf membrnne-cytoskclchll associtilioll in the sarcolemma would 
explain the combined phenotype of skin fragility and progressi\'e muscle degeneration in 
EB-MD. 
lIB17 
lNTERLEUKIN 7 DEFICIENT MICE. Benjamin E Rich and Philip Leder, 
Department of Genetics, Harvard Medical School, 200 Longwood Avenue, Boston, MA 
02115 
A growing body of experimental data describes Ihe biology of intericukin-7 (lL-
7). Several observations have linked IL-7 specifically to the skin. IL-7 is expressed by 
skin keratinocytes in a regulated fashion and this expression sup pons the viability of 
dendritic epidermal T cells. Three differenl lines of IL-7 transgenic mice have been 
generated in which lymphoid or epidermal expression of IL-7 Icads to culaneous 
infiltrates of lymphocytes. Finally, many cutaneous T cell lymphomas express and 
respond to IL-7. These observations, while not conclusive, suggest that IL-7 may be an 
especially significanl fac tor for cutaneous lymphocytes. Therefore IL-7 is likely to be 
imponant for normal cutaneous immunity and 10 be involved in cenain skin diseases. 
To examine the biologic role of IL-7 in living animals, a defective .allele of the IL-
7 gene was introduced into the germ line of mice. Mice homozygous for this aUele have 
sharply cunailed expansion of lymphoid cells. This is evident in a significant reduction 
but not elimination of lymphoid cells in the spleen, thymus and bone marrow of these 
mice. Small numbers of B cells arc detected in Ihe bone marrow. S imilarly, the few 
Ihymocytes presenl in IL-7 deficient mice express CD4 and/or CDS markers associaled 
wilh T cell maturation. Thus the signal transmitted by TL-7 plays a central role in Ihe 
expansion of lymphoid populations during muturation while it m ay not be absolutely 
requjl'ed for maturation. A transgene containing an IL-7 cDNA under the control of 
immunoglobulin heavy chain gene promoter and enhancer sequences directs expression 
of J!...-7 to Iympboid cells. This transgene was found to restore T and B cells of IL-7 
deficient mice to approximatcly normal levels. This complementation confirms that the 
lymphoid defect is specifically due to disruption of the IL-7 gene and suggesls that the 
number oflymphoid cells may be regulated by Ihe level of TL-7 expression. 
